BNet Technology & Business Networking Session 2010

Industry Overview
In 2004, the world pharmaceutical excipients market is estimated
to be $3.00billion. European total market revenue is estimated to
be $1.13billion. ecent dru! problems and dru! "ailures in
di""erent clinical sta!es have raised the cost concern in
pharmaceutical industr#. $harmaceutical companies see
excipients as cost reduction opportunit#. %ith this, the &'( o"
).3 representin! a revenue o" $1.3*billion in 200+.
$harmaceutical base
Technology
,he product is a proprietar# pharmaceutical base "ormulated usin! palm oil and palm kernel oil, o""ers a
cost e""ective alternative to imported pharmaceutical base excipients. It is stable, non-irritatin! to the
bod#, chemicall# and ph#siolo!icall# inert and compatible with a variet# o" dru!s. Its thermostabilit#
allows a lar!er meltin! ran!e "rom 4) & to .0 & durin! product preparation sta!e. /nder room
temperature stora!e condition, the product is estimated to be oxidativel# stable "or 0 #ears. ,he product is
sa"e to use, non-toxic and non irritant which are validated b# various third parties e.!. &ovance and 112
/nited 3in!dom. 1ince the content is 1004 based on local palm oil, it is there"ore assured 5'2'2. ,he
breakthrou!h technolo!# has earned acclaim o" the broader scienti"ic communit# with international
publications, e.!. 6ournal o" $harmaceutical ,echnolo!#, 6ournal o" ,hermal 'nal#sis and 7ru!
7evelopment and Industrial $harmac#.
R&D Profile
8leopharma 1dn 9hd is a :oint-venture compna# o" presti!ious
public universit# and local partner. It "ocuses on the development
o" semi-solid pharmaceutical base "rom local palm oil, with pilot
plant to be read# "or operation b# earl# ;2 2011. ,he innovation
won various awards at international and national technolo!#
exhibitions "rom 2004 to 2010.
HAMIN: ROBUST HALAL BIOTECH
PHARMACEUTICAL EXCIPIENT/BASE
FOR DRUG DELIVERY
Opportunity
%e are lookin! "or local pharmaceutical companies as their
potential client .
$harmaceutical dosa!e "orms